Kali Inc Anticipates Finalizing NCM Biotech Acquisition By Friday Securing Cannabis Extraction Patent
November 06 2018 - 9:39AM
InvestorsHub NewsWire
Sarasota, FL -- November 6, 2018 --
InvestorsHub NewsWire -- Kali, Inc. (USOTC:
KALY) today announced plans to finalize the previously
announced pending acquisition of NCM Biotech. Kali and NCM
Biotech, have recently announced a letter of intent agreement
regarding the pending acquisition. NCM Biotech is the
developer and owner of a patented cannabis extraction process -
U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR
PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS
PLANT.” Kali and NCM are meeting this week in Dallas to both
consummate the acquisition an strategize with Puration, Inc. (PURA)
and Nouveau Life Pharmaceuticals, Inc. on the recent formation of a
joint venture (JV) company to develop cannabis pharmaceutical
products. Kali has partnered with
PURA and
NOUV to form US Cannabis Health, a JV company formed for the
development of cannabis pharmaceutical and wellness products.
The cannabis pharmaceuticals market is forecasted to reach a
$50 billion sales by
2029.
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
CONTACT:
Kali, Inc.
941.444.6994
management@wavemarineservices.com
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024